Adénomyose

review OA: closed CC0 ⤵ 17 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This paper is about adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Diagnostic adenomyosis is done by pathologist (grade A). Adenomyosis is usually asymptomatic (grade C). Symptomatic adenomyosis gives pains and/or bleedings (grade C). Hysterosalpingography is not included in diagnostic strategy (grade B). Sonography has a good sensitivity and can be exclusively used for therapeutic strategy (grade B). MRI is pertinent but only useful in case of associated lesions (grade B). Hysterectomy is the gold standard for symptomatic patients without desire of pregnancy (grade B). Medical treatments are: IUD with levonorgestrel, Gn-RH analog, antigonadotrope progestin (grade C). Uterine artery embolisation is not recommended (professional agreement). Endometrial resection/destruction are indicated in case of menorraghia (grade C).

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Embolization, Therapeutic Endometriosis Endosonography Endosonography Female Humans Hysterectomy Hysterectomy Intrauterine Devices, Medicated Magnetic Resonance Imaging Magnetic Resonance Imaging Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (17)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:06.633332+00:00
License: CC0 · commercial use OK